QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
ý | Accelerated filer | ☐ | ||||
Non-accelerated filer | ☐ | Smaller reporting company | ||||
Emerging growth company |
Page | ||
Part I. Financial Information | ||
Item 1. | ||
Condensed Consolidated Balance Sheets — September 30, 2019 and December 31, 2018 | ||
Condensed Consolidated Statements of Income — Three and nine months ended September 30, 2019 and 2018 | ||
Condensed Consolidated Statements of Changes in Equity — Nine months ended September 30, 2019 and 2018 | ||
Condensed Consolidated Statements of Cash Flows — Nine months ended September 30, 2019 and 2018 | ||
Item 2. | ||
Item 3. | ||
Item 4. | ||
Part II. Other Information | ||
Item 1. | ||
Item 1A. | ||
Item 2. | ||
Item 6. | ||
September 30, 2019 | December 31, 2018 | ||||||
ASSETS | |||||||
Current assets: | |||||||
Cash | $ | $ | |||||
Receivables: | |||||||
Patient accounts receivable | |||||||
Other receivables | |||||||
Amounts due from governmental entities | |||||||
Total receivables | |||||||
Prepaid income taxes | |||||||
Prepaid expenses | |||||||
Other current assets | |||||||
Total current assets | |||||||
Property, building and equipment, net of accumulated depreciation of $66,219 and $55,253, respectively | |||||||
Goodwill | |||||||
Intangible assets, net of accumulated amortization of $16,127 and $15,176, respectively | |||||||
Assets held for sale | |||||||
Operating lease right of use asset | |||||||
Other assets | |||||||
Total assets | $ | $ | |||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable and other accrued liabilities | $ | $ | |||||
Salaries, wages, and benefits payable | |||||||
Self-insurance reserves | |||||||
Current operating lease liabilities | |||||||
Current portion of long-term debt | |||||||
Amounts due to governmental entities | |||||||
Total current liabilities | |||||||
Deferred income taxes | |||||||
Income taxes payable | |||||||
Revolving credit facility | |||||||
Long term notes payable | |||||||
Operating lease payable | |||||||
Total liabilities | |||||||
Noncontrolling interest — redeemable | |||||||
Stockholders’ equity: | |||||||
LHC Group, Inc. stockholders’ equity: | |||||||
Preferred stock – $0.01 par value; 5,000,000 shares authorized; none issued or outstanding | |||||||
Common stock — $0.01 par value; 60,000,000 shares authorized; 35,857,938 and 35,636,414 shares issued in 2019 and 2018, respectively | |||||||
Treasury stock — 5,060,266 and 4,958,721 shares at cost, respectively | ( | ) | ( | ) | |||
Additional paid-in capital | |||||||
Retained earnings | |||||||
Total LHC Group, Inc. stockholders’ equity | |||||||
Noncontrolling interest — non-redeemable | |||||||
Total equity | |||||||
Total liabilities and equity | $ | $ |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||||||
Net service revenue | $ | $ | $ | $ | |||||||||||
Cost of service revenue | |||||||||||||||
Gross margin | |||||||||||||||
General and administrative expenses | |||||||||||||||
Other intangible impairment charge | |||||||||||||||
Operating income | |||||||||||||||
Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | |||||||
Income before income taxes and noncontrolling interest | |||||||||||||||
Income tax expense | |||||||||||||||
Net income | |||||||||||||||
Less net income attributable to noncontrolling interests | |||||||||||||||
Net income attributable to LHC Group, Inc.’s common stockholders | $ | $ | $ | $ | |||||||||||
Earnings per share: | |||||||||||||||
Basic | $ | $ | $ | $ | |||||||||||
Diluted | $ | $ | $ | $ | |||||||||||
Weighted average shares outstanding: | |||||||||||||||
Basic | |||||||||||||||
Diluted |
Common Stock | Additional Paid-In Capital | Retained Earnings | Noncontrolling Interest Non Redeemable | Total Equity | |||||||||||||||||||||||||
Issued | Treasury | ||||||||||||||||||||||||||||
Amount | Shares | Amount | Shares | ||||||||||||||||||||||||||
Balance as of December 31, 2018 | $ | $ | ( | ) | $ | $ | $ | $ | |||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||
Acquired noncontrolling interest | — | — | — | — | — | — | |||||||||||||||||||||||
Noncontrolling interest distributions | — | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||
NCI acquired, net of sales | — | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||
Nonvested stock compensation | — | — | — | — | — | — | |||||||||||||||||||||||
Restricted share grants | — | — | — | — | — | ||||||||||||||||||||||||
Treasury shares redeemed to pay income tax | — | — | ( | ) | ( | ) | — | — | ( | ) | |||||||||||||||||||
Issuance of common stock under Employee Stock Purchase Plan | — | — | — | — | — | ||||||||||||||||||||||||
Balance as of March 31, 2019 | $ | $ | ( | ) | $ | $ | $ | $ | |||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||
Acquired noncontrolling interest | — | — | — | — | — | — | |||||||||||||||||||||||
Noncontrolling interest distributions | — | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||
NCI acquired, net of sales | — | — | — | — | ( | ) | — | ( | ) | ||||||||||||||||||||
Nonvested stock compensation | — | — | — | — | — | — | |||||||||||||||||||||||
Restricted share grants | — | — | — | — | — | — | — | ||||||||||||||||||||||
Treasury shares redeemed to pay income tax | — | — | ( | ) | — | — | ( | ) | |||||||||||||||||||||
Issuance of common stock under Employee Stock Purchase Plan | — | — | — | — | — | ||||||||||||||||||||||||
Balance as of June 30, 2019 | $ | $ | ( | ) | $ | $ | $ | $ | |||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||
Acquired noncontrolling interest | — | — | — | — | — | — | |||||||||||||||||||||||
Noncontrolling interest distributions | — | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||
NCI acquired, net of sales | — | — | — | — | — | ( | ) | ||||||||||||||||||||||
Nonvested stock compensation | — | — | — | — | — | — | |||||||||||||||||||||||
Restricted share grants | — | — | — | — | — | ||||||||||||||||||||||||
Treasury shares redeemed to pay income tax | — | — | ( | ) | — | — | ( | ) | |||||||||||||||||||||
Issuance of common stock under Employee Stock Purchase Plan | — | — | — | — | — | ||||||||||||||||||||||||
Balance as of September 30, 2019 | $ | $ | ( | ) | $ | $ | $ | $ |
Common Stock | Additional Paid-In Capital | Retained Earnings | Noncontrolling Interest Non Redeemable | Total Equity | |||||||||||||||||||||||||
Issued | Treasury | ||||||||||||||||||||||||||||
Amount | Shares | Amount | Shares | ||||||||||||||||||||||||||
Balance as of December 31, 2017 | $ | $ | ( | ) | $ | $ | $ | $ | |||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||
Acquired noncontrolling interest | — | — | — | — | — | — | |||||||||||||||||||||||
Noncontrolling interest distributions | — | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||
Sale of noncontrolling interest | — | — | — | — | ( | ) | — | ||||||||||||||||||||||
Purchase of additional controlling interest | — | — | — | — | ( | ) | — | ( | ) | ( | ) | ||||||||||||||||||
Nonvested stock compensation | — | — | — | — | — | — | |||||||||||||||||||||||
Issuance of vested stock | — | — | ( | ) | — | — | — | ||||||||||||||||||||||
Treasury shares redeemed to pay income tax | — | — | ( | ) | — | — | — | ( | ) | ||||||||||||||||||||
Issuance of common stock under Employee Stock Purchase Plan | — | — | — | — | — | ||||||||||||||||||||||||
Balance as of March 31, 2018 | $ | $ | ( | ) | $ | $ | $ | $ | |||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||
Acquired noncontrolling interest | — | — | — | — | — | — | |||||||||||||||||||||||
Noncontrolling interest distributions | — | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||
Sale of noncontrolling interest | — | — | — | — | ( | ) | — | ( | ) | ||||||||||||||||||||
Nonvested stock compensation | — | — | — | — | — | — | |||||||||||||||||||||||
Issuance of vested stock | — | — | — | — | — | — | — | ||||||||||||||||||||||
Treasury shares redeemed to pay income tax | — | — | ( | ) | — | — | — | ( | ) | ||||||||||||||||||||
Merger consideration | — | — | — | — | |||||||||||||||||||||||||
Issuance of common stock under Employee Stock Purchase Plan | — | — | — | — | — | ||||||||||||||||||||||||
Balance as of June 30, 2018 | $ | $ | ( | ) | $ | $ | $ | $ | |||||||||||||||||||||
Net income | — | — | — | — | — | ||||||||||||||||||||||||
Acquired noncontrolling interest | — | — | — | — | — | — | |||||||||||||||||||||||
Noncontrolling interest distributions | — | — | — | — | — | — | ( | ) | ( | ) | |||||||||||||||||||
Purchase of additional controlling interest | — | — | — | — | — | ( | ) | ||||||||||||||||||||||
Nonvested stock compensation | — | — | — | — | — | — | |||||||||||||||||||||||
Issuance of vested stock | — | — | — | — | — | — | — | ||||||||||||||||||||||
Treasury shares redeemed to pay income tax | — | — | ( | ) | — | — | — | ( | ) | ||||||||||||||||||||
Issuance of common stock under Employee Stock Purchase Plan | — | — | — | — | |||||||||||||||||||||||||
Balance as of September 30, 2018 | $ | $ | ( | ) | $ | $ | $ | $ |
Nine Months Ended September 30, | |||||||
2019 | 2018 | ||||||
Operating activities: | |||||||
Net income | $ | $ | |||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Depreciation and amortization expense | |||||||
Amortization of operating lease right of use asset | |||||||
Stock-based compensation expense | |||||||
Deferred income taxes | |||||||
Loss (gain) on disposal of assets | |||||||
Impairment of intangibles and other | |||||||
Changes in operating assets and liabilities, net of acquisitions: | |||||||
Receivables | ( | ) | ( | ) | |||
Prepaid expenses and other assets | ( | ) | |||||
Prepaid income taxes | |||||||
Accounts payable and accrued expenses | ( | ) | |||||
Income taxes payable | ( | ) | ( | ) | |||
Net amounts due to/from governmental entities | ( | ) | ( | ) | |||
Net cash provided by operating activities | |||||||
Investing activities: | |||||||
Purchases of property, building and equipment | ( | ) | ( | ) | |||
Cash paid for acquisitions, net of cash acquired | ( | ) | |||||
Net cash used in investing activities | ( | ) | ( | ) | |||
Financing activities: | |||||||
Proceeds from line of credit | |||||||
Payments on line of credit | ( | ) | ( | ) | |||
Proceeds from employee stock purchase plan | |||||||
Payments on debt | ( | ) | ( | ) | |||
Payments on deferred financing fees | ( | ) | |||||
Noncontrolling interest distributions | ( | ) | ( | ) | |||
Withholding taxes paid on stock-based compensation | ( | ) | ( | ) | |||
Purchase of additional controlling interest | ( | ) | ( | ) | |||
Exercise of options | — | ||||||
Sale of noncontrolling interest | |||||||
Net cash used in financing activities | ( | ) | ( | ) | |||
Change in cash | ( | ) | |||||
Cash at beginning of period | |||||||
Cash at end of period | $ | $ | |||||
Supplemental disclosures of cash flow information: | |||||||
Interest paid | $ | $ | |||||
Income taxes paid | $ | $ |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||
Home health: | |||||||||||
Medicare | % | % | % | % | |||||||
Managed Care, Commercial, and Other | |||||||||||
% | % | % | % | ||||||||
Hospice: | |||||||||||
Medicare | % | % | % | % | |||||||
Managed Care, Commercial, and Other | |||||||||||
% | % | % | % | ||||||||
Home and Community-Based Services: | |||||||||||
Medicaid | % | % | % | % | |||||||
Managed Care, Commercial, and Other | |||||||||||
% | % | % | % | ||||||||
Facility-Based Services: | |||||||||||
Medicare | % | % | % | % | |||||||
Managed Care, Commercial, and Other | |||||||||||
% | % | % | % | ||||||||
HCI: | |||||||||||
Medicare | % | % | % | % | |||||||
Managed Care, Commercial, and Other | |||||||||||
% | % | % | % |
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
2019 | 2018 | 2019 | 2018 | ||||||||
Weighted average number of shares outstanding for basic per share calculation | |||||||||||
Effect of dilutive potential shares: | |||||||||||
Nonvested stock | |||||||||||
Adjusted weighted average shares for diluted per share calculation | |||||||||||
Anti-dilutive shares |
Merger consideration | ||||
Stock | $ | |||
Fair value of total consideration transferred | ||||
Recognized amounts of identifiable assets acquired and liabilities assumed: | ||||
Cash and cash equivalents | ||||
Patient accounts receivable | ||||
Prepaid income taxes | ||||
Prepaid expenses and other current assets | ||||
Property and equipment | ||||
Trade names | ||||
Certificates of needs/licenses | ||||
Customer relationships | ||||
Assets held for sale | ||||
Deferred income taxes | ||||
Accounts payable | ( | ) | ||
Accrued other liabilities | ( | ) | ||
Seller notes payable | ( | ) | ||
NCI - Redeemable | ( | ) | ||
Long term income taxes payable | ( | ) | ||
Line of credit | ( | ) | ||
NCI - Nonredeemable | ( | ) | ||
Other assets and (liabilities), net | ( | ) | ||
Total identifiable assets and liabilities | ||||
Goodwill | $ |
Consideration | ||||
Cash | $ | |||
Fair value of total consideration transferred | ||||
Recognized amounts of identifiable assets acquired and liabilities assumed: | ||||
Trade name | ||||
Certificates of need/licenses | ||||
Other assets and (liabilities), net | ( | ) | ||
Total identifiable assets | ||||
Noncontrolling interest | ||||
Goodwill, including noncontrolling interest of $6,367 | $ |
Home health reporting unit | Hospice reporting unit | Home and community-based services reporting unit | Facility-based reporting unit | HCI reporting unit | Total | ||||||||||||||||||
Goodwill | |||||||||||||||||||||||
Balance as of December 31, 2018 | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Acquisitions | |||||||||||||||||||||||
Noncontrolling interests | |||||||||||||||||||||||
Adjustments and disposals | |||||||||||||||||||||||
Balance as of September 30, 2019 | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Intangible assets | |||||||||||||||||||||||
Balance as of December 31, 2018 | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Acquisitions | |||||||||||||||||||||||
Adjustments and disposals | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||
Amortization | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Balance as of September 30, 2019 | $ | $ | $ | $ | $ | $ |
2019 | 2018 | ||||||
Indefinite-lived intangible assets: | |||||||
Trade Names | $ | $ | |||||
Certificates of Need/Licenses | |||||||
Net Total | $ | $ | |||||
Definite-lived intangible assets: | |||||||
Trade Names | |||||||
Gross carrying amount | $ | $ | |||||
Accumulated amortization | ( | ) | ( | ) | |||
Net total | $ | $ | |||||
Non-compete agreements | |||||||
Gross carrying amount | $ | $ | |||||
Accumulated amortization | ( | ) | ( | ) | |||
Net total | $ | $ | |||||
Customer relationships | |||||||
Gross carrying amount | $ | $ | |||||
Accumulated amortization | ( | ) | ( | ) | |||
Net total | $ | $ | |||||
Total definite-lived intangible assets | |||||||
Gross carrying amount | $ | $ | |||||
Accumulated amortization | ( | ) | ( | ) | |||
Net total | $ | $ | |||||
Total intangible assets: | |||||||
Gross carrying amount | $ | $ | |||||
Accumulated amortization | ( | ) | ( | ) | |||
Net total | $ | $ |
Restricted stock | Options | ||||||||||||
Number of shares | Weighted average grant date fair value | Number of shares | Weighted average grant date fair value | ||||||||||
Share grants outstanding as of December 31, 2018 | $ | $ | |||||||||||
Granted | $ | $ | |||||||||||
Vested or exercised | ( | ) | $ | ( | ) | $ | |||||||
Share grants outstanding as of September 30, 2019 | $ | $ |
Number of shares | Per share price | |||||
Shares available as of December 31, 2018 | ||||||
Shares issued during the three months ended March 31, 2019 | $ | |||||
Shares issued during the three months ended June 30, 2019 | $ | |||||
Shares issued during the three months ended September 30, 2019 | $ | |||||
Shares available as of September 30, 2019 |
Balance as of December 31, 2018 | $ | ||
Net income attributable to noncontrolling interest-redeemable | |||
Noncontrolling interest-redeemable distributions | ( | ) | |
Balance as of September 30, 2019 | $ |
Nine Months Ended September 30, 2019 | ||||
Cash paid for operating lease liabilities | $ | |||
Right-of-use assets obtained in exchange for new operating lease liabilities | $ | |||
Weighted-average remaining lease term | ||||
Weighted-average discount rate | % |
Year ending December 31, | ||||
2019 (remaining) | $ | |||
2020 | ||||
2021 | ||||
2022 | ||||
2023 (and thereafter) | ||||
Total future minimum lease payments | ||||
Less: Imputed interest | ( | ) | ||
Total | $ |
Three Months Ended September 30, 2019 | |||||||||||||||||||||||
Home health services | Hospice services | Home and community-based services | Facility-based services | HCI | Total | ||||||||||||||||||
Net service revenue | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Cost of service revenue | |||||||||||||||||||||||
General and administrative expenses | |||||||||||||||||||||||
Other intangible impairment charge | |||||||||||||||||||||||
Operating income | |||||||||||||||||||||||
Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Income before income taxes and noncontrolling interest | |||||||||||||||||||||||
Income tax expense | |||||||||||||||||||||||
Net income | |||||||||||||||||||||||
Less net income (loss) attributable to non controlling interests | ( | ) | ( | ) | ( | ) | |||||||||||||||||
Net income attributable to LHC Group, Inc.'s common stockholder | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Total assets | $ | $ | $ | $ | $ | $ |
Three Months Ended September 30, 2018 | |||||||||||||||||||||||
Home health services | Hospice services | Home and community-based services | Facility-based services | HCI | Total | ||||||||||||||||||
Net service revenue | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Cost of service revenue | |||||||||||||||||||||||
General and administrative expenses | |||||||||||||||||||||||
Other intangible impairment charge | |||||||||||||||||||||||
Operating income (loss) | ( | ) | ( | ) | |||||||||||||||||||
Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Income (loss) before income taxes and noncontrolling interest | ( | ) | ( | ) | |||||||||||||||||||
Income tax expense (benefit) | ( | ) | ( | ) | |||||||||||||||||||
Net income (loss) | ( | ) | ( | ) | |||||||||||||||||||
Less net income (loss) attributable to noncontrolling interests | ( | ) | |||||||||||||||||||||
Net income (loss) attributable to LHC Group, Inc.'s common stockholders | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | |||||||||||||
Total assets | $ | $ | $ | $ | $ | $ |
Nine Months Ended September 30, 2019 | |||||||||||||||||||||||
Home health services | Hospice services | Home and community-based services | Facility-based services | HCI | Total | ||||||||||||||||||
Net service revenue | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Cost of service revenue | |||||||||||||||||||||||
General and administrative expenses | |||||||||||||||||||||||
Other intangible impairment charge | |||||||||||||||||||||||
Operating income | |||||||||||||||||||||||
Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Income before income taxes and noncontrolling interest | |||||||||||||||||||||||
Income tax expense | |||||||||||||||||||||||
Net income | |||||||||||||||||||||||
Less net income (loss) attributable to non controlling interests | ( | ) | ( | ) | |||||||||||||||||||
Net income attributable to LHC Group, Inc.'s common stockholder | $ | $ | $ | $ | $ | $ |
Nine Months Ended September 30, 2018 | |||||||||||||||||||||||
Home health services | Hospice services | Home and community-based services | Facility-based services | HCI | Total | ||||||||||||||||||
Net service revenue | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Cost of service revenue | |||||||||||||||||||||||
General and administrative expenses | |||||||||||||||||||||||
Other intangible impairment charge | |||||||||||||||||||||||
Operating income | ( | ) | |||||||||||||||||||||
Interest expense | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Income (loss) before income taxes and noncontrolling interest | ( | ) | |||||||||||||||||||||
Income tax expense (benefit) | ( | ) | |||||||||||||||||||||
Net income (loss) | ( | ) | |||||||||||||||||||||
Less net income (loss) attributable to noncontrolling interests | ( | ) | ( | ) | |||||||||||||||||||
Net income (loss) attributable to LHC Group, Inc.'s common stockholders | $ | $ | $ | $ | ( | ) | $ | $ |
• | our expectations regarding financial condition or results of operations for periods after September 30, 2019; |
• | our critical accounting policies; |
• | our business strategies and our ability to grow our business; |
• | our participation in the Medicare and Medicaid programs; |
• | the reimbursement levels of Medicare and other third-party payors; |
• | the prompt receipt of payments from Medicare and other third-party payors; |
• | our future sources of and needs for liquidity and capital resources; |
• | the effect of any regulatory changes or anticipated regulatory changes; |
• | the effect of any changes in market rates on our operations and cash flows; |
• | our ability to obtain financing; |
• | our ability to make payments as they become due; |
• | the outcomes of various routine and non-routine governmental reviews, audits and investigations; |
• | our expansion strategy, the successful integration of recent acquisitions and, if necessary, the ability to relocate or restructure our current facilities; |
• | the value of our proprietary technology; |
• | the impact of legal proceedings; |
• | our insurance coverage; |
• | our competitors and our competitive advantages; |
• | our ability to attract and retain valuable employees; |
• | the price of our stock; |
• | our compliance with environmental, health and safety laws and regulations; |
• | our compliance with health care laws and regulations; |
• | the impact of federal and state government regulation on our business; and |
• | the impact of changes in future interpretations of fraud, anti-kickback, or other laws. |
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||
Reporting segment | 2019 | 2018 | 2019 | 2018 | ||||||||
Home health services | 71.1 | % | 71.0 | % | 71.9 | % | 71.1 | % | ||||
Hospice services | 11.7 | 10.5 | 10.9 | 11.3 | ||||||||
Home and community-based services | 10.1 | 10.4 | 10.2 | 9.2 | ||||||||
Facility-based services | 5.4 | 5.5 | 5.4 | 6.6 | ||||||||
Healthcare innovations services | 1.7 | 2.6 | 1.6 | 1.8 | ||||||||
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % |
Description | Rate per patient day | |||
Routine Home Care days 1-60 | $ | 194.50 | ||
Routine Home Care days 60+ | $ | 153.72 | ||
Continuous Home Care | $ | 1,395.63 | ||
Full rate = 24 hours of care | ||||
$58.15 = hourly rate | ||||
Inpatient Respite Care | $ | 450.10 | ||
General Inpatient Care | $ | 1,021.25 |
2019 | 2018 | Increase (Decrease) | ||||||||||||||||
Net service revenue | $ | 528,499 | $ | 507,043 | $ | 21,456 | ||||||||||||
Cost of service revenue | 334,768 | 63.3 | % | 322,196 | 63.5 | % | 12,572 | |||||||||||
General and administrative expenses | 146,829 | 27.8 | 149,572 | 29.5 | (2,743 | ) | ||||||||||||
Other intangible impairment charge | 197 | 345 | (148 | ) | ||||||||||||||
Interest expense | (2,596 | ) | (3,264 | ) | (668 | ) | ||||||||||||
Income tax expense | 9,508 | 27.9 | (1 | ) | 6,685 | 28.2 | (1) | 2,823 | ||||||||||
Net income attributable to noncontrolling interests | 4,534 | 3,751 | 783 | |||||||||||||||
Net income attributable to LHC Group, Inc.’s common stockholders | $ | 30,067 | $ | 21,230 | $ | 8,837 |
(1) | Effective tax rate as a percentage of income from continuing operations attributable to our common stockholders, excluding the excess tax benefits realized and a change in our unrecognized tax position. For a discussion of our unrecognized tax position, which was assumed with the Merger on April 1, 2018, see Note 12 of the Notes to Condensed Consolidated Financial Statements, which is incorporated herein by reference. |
Three Months Ended September 30, 2019 | |||||||||||||||||||||||||
Same Store(1) | De Novo(2) | Organic(3) | Organic Growth (Loss) % | Acquired(4) | Total | Total Growth (Loss) % | |||||||||||||||||||
Home health services | |||||||||||||||||||||||||
Revenue | $ | 230,097 | $ | — | $ | 230,097 | 7.9 | % | $ | 151,205 | $ | 381,302 | 4.5 | % | |||||||||||
Revenue Medicare | $ | 152,920 | $ | — | $ | 152,920 | 4.1 | $ | 110,395 | $ | 263,315 | 1.0 | |||||||||||||
Admissions | 57,634 | — | 57,634 | 11.1 | 40,013 | 97,647 | 5.4 | ||||||||||||||||||
Medicare Admissions | 32,831 | — | 32,831 | 5.4 | 24,665 | 57,496 | 0.7 | ||||||||||||||||||
Average Census | 47,248 | — | 47,248 | 7.2 | 29,657 | 76,905 | 1.9 | ||||||||||||||||||
Average Medicare Census | 29,624 | — | 29,624 | 2.6 | 19,392 | 49,016 | (1.9 | ) | |||||||||||||||||
Home Health Episodes | 54,893 | — | 54,893 | 3.6 | 37,063 | 91,956 | (1.5 | ) | |||||||||||||||||
Hospice services | |||||||||||||||||||||||||
Revenue | $ | 47,678 | $ | — | $ | 47,678 | 6.0 | $ | 10,506 | $ | 58,184 | 8.2 | |||||||||||||
Revenue Medicare | $ | 43,980 | $ | — | $ | 43,980 | 12.7 | $ | 9,536 | $ | 53,516 | 13.6 | |||||||||||||
Admissions | 3,674 | — | 3,674 | 2.1 | 848 | 4,522 | (0.8 | ) | |||||||||||||||||
Medicare Admissions | 3,213 | — | 3,213 | 2.2 | 774 | 3,987 | 1.4 | ||||||||||||||||||
Average Census | 3,481 | — | 3,481 | 9.2 | 706 | 4,187 | 11.3 | ||||||||||||||||||
Average Medicare Census | 3,244 | — | 3,244 | 10.7 | 639 | 3,883 | 12.5 | ||||||||||||||||||
Patient days | 323,748 | — | 323,748 | 10.5 | 61,416 | 385,164 | 11.3 | ||||||||||||||||||
Home and community-based services | |||||||||||||||||||||||||
Revenue | $ | 15,411 | $ | — | $ | 15,411 | 4.3 | $ | 39,160 | $ | 54,571 | 2.0 | |||||||||||||
Billable hours | 674,954 | — | 674,954 | 40.0 | 1,602,030 | 2,276,984 | (0.8 | ) | |||||||||||||||||
Facility-based services | |||||||||||||||||||||||||
LTACHs | |||||||||||||||||||||||||
Revenue | $ | 25,849 | $ | — | $ | 25,849 | 8.5 | $ | 203 | $ | 26,052 | 1.8 | |||||||||||||
Patient days | 18,776 | — | 18,776 | (8.9 | ) | 142 | 18,918 | (12.5 | ) | ||||||||||||||||
Other facility-based services | |||||||||||||||||||||||||
Revenue | $ | 3,135 | $ | — | $ | 3,135 | 7.6 | $ | — | $ | 3,135 | 7.6 | |||||||||||||
HCI | |||||||||||||||||||||||||
Revenue | $ | — | $ | — | $ | — | — | $ | 8,782 | $ | 8,782 | (34.9 | ) | ||||||||||||
Consolidated | |||||||||||||||||||||||||
Revenue | $ | 322,170 | $ | — | $ | 322,170 | 7.5 | $ | 209,856 | $ | 532,026 | 3.5 |
(1) | Same store — location that has been in service with us for greater than 12 months. |
(2) | De Novo — internally developed location that has been in service with us for 12 months or less. |
(3) | Organic — combination of same store and de novo. |
(4) | Acquired — purchased location that has been in service with us for 12 months or less, including all legacy Almost Family locations for the period after April 1, 2018. Almost Family locations remain counted as acquired locations due to continued system integrations, which will be completed by the end of 2019. |
Three Months Ended September 30, | ||||||||||||
2019 | % of Net Service Revenue | 2018 | % of Net Service Revenue | |||||||||
Revenue | $ | 532,026 | $ | 514,118 | ||||||||
Less: Implicit price concession | 3,527 | 0.7 | % | 7,075 | 1.4 | % | ||||||
Net service revenue | $ | 528,499 | $ | 507,043 |
Three Months Ended September 30, | |||||||||||||
2019 | 2018 | ||||||||||||
Home health services | |||||||||||||
Salaries, wages and benefits | $ | 217,510 | 57.9 | % | $ | 203,463 | 56.5 | % | |||||
Transportation | 11,161 | 3.0 | 11,450 | 3.2 | |||||||||
Supplies and services | 8,743 | 2.3 | 7,852 | 2.2 | |||||||||
Total | $ | 237,414 | 63.2 | % | $ | 222,765 | 61.9 | % | |||||
Hospice services | |||||||||||||
Salaries, wages and benefits | $ | 26,336 | 42.5 | % | $ | 24,763 | 46.8 | % | |||||
Transportation | 2,023 | 3.3 | 1,931 | 3.6 | |||||||||
Supplies and services | 7,460 | 12.0 | 7,846 | 14.8 | |||||||||
Total | $ | 35,819 | 57.8 | % | $ | 34,540 | 65.2 | % | |||||
Home and community-based services | |||||||||||||
Salaries, wages and benefits | $ | 38,943 | 72.9 | % | $ | 39,100 | 74.1 | % | |||||
Transportation | 534 | 1.0 | 576 | 1.1 | |||||||||
Supplies and services | 217 | 0.4 | 184 | 0.3 | |||||||||
Total | $ | 39,694 | 74.3 | % | $ | 39,860 | 75.5 | % | |||||
Facility-based services | |||||||||||||
Salaries, wages and benefits | $ | 13,302 | 46.3 | % | $ | 13,784 | 49.4 | % | |||||
Transportation | 76 | 0.3 | 89 | 0.3 | |||||||||
Supplies and services | 5,130 | 17.9 | 6,273 | 22.5 | |||||||||
Total | $ | 18,508 | 64.5 | % | $ | 20,146 | 72.2 | % | |||||
HCI | |||||||||||||
Salaries, wages and benefits | $ | 3,196 | 36.5 | % | $ | 4,674 | 34.8 | % | |||||
Transportation | 99 | 1.1 | 177 | 1.3 | |||||||||
Supplies and services | 38 | 0.4 | 34 | 0.3 | |||||||||
Total | $ | 3,333 | 38.0 | % | $ | 4,885 | 36.4 | % | |||||
Consolidated | |||||||||||||
Total | $ | 334,768 | 63.3 | % | $ | 322,196 | 63.5 | % |
Three Months Ended September 30, | |||||||||||||
2019 | 2018 | ||||||||||||
Home health services | |||||||||||||
General and administrative | $ | 105,761 | 28.2 | % | $ | 102,633 | 28.5 | % | |||||
Depreciation and amortization | 2,557 | 0.7 | 2,479 | 0.7 | |||||||||
Total | $ | 108,318 | 28.9 | % | $ | 105,112 | 29.2 | % | |||||
Hospice services | |||||||||||||
General and administrative | $ | 14,763 | 23.8 | % | $ | 14,048 | 26.5 | % | |||||
Depreciation and amortization | 455 | 0.7 | 637 | 1.2 | |||||||||
Total | $ | 15,218 | 24.5 | % | $ | 14,685 | 27.7 | % | |||||
Home and community-based services | |||||||||||||
General and administrative | $ | 10,471 | 19.6 | % | $ | 12,771 | 24.2 | % | |||||
Depreciation and amortization | 338 | 0.6 | 151 | 0.3 | |||||||||
Total | $ | 10,809 | 20.2 | % | $ | 12,922 | 24.5 | % | |||||
Facility-based services | |||||||||||||
General and administrative | $ | 8,713 | 30.3 | % | $ | 9,056 | 32.5 | % | |||||
Depreciation and amortization | 785 | 2.7 | 767 | 2.7 | |||||||||
Total | $ | 9,498 | 33.0 | % | $ | 9,823 | 35.2 | % | |||||
HCI | |||||||||||||
General and administrative | $ | 2,709 | 31.0 | % | $ | 6,624 | 49.4 | % | |||||
Depreciation and amortization | 277 | 3.2 | 406 | 3.0 | |||||||||
Total | $ | 2,986 | 34.2 | % | $ | 7,030 | 52.4 | % | |||||
Consolidated | |||||||||||||
Total | $ | 146,829 | 27.8 | % | $ | 149,572 | 29.5 | % |
2019 | 2018 | Increase (Decrease) | ||||||||||||||||
Net service revenue | $ | 1,548,926 | $ | 1,300,121 | $ | 248,805 | ||||||||||||
Cost of service revenue | 981,620 | 63.4 | % | 831,818 | 64.0 | % | 149,802 | |||||||||||
General and administrative expenses | 440,634 | 28.4 | 390,817 | 30.1 | 49,817 | |||||||||||||
Other intangible impairment charge | 7,534 | 1,123 | 6,411 | |||||||||||||||
Interest expense | (8,533 | ) | (7,916 | ) | 617 | |||||||||||||
Income tax expense | 22,665 | 27.7 | (1 | ) | 14,832 | 27.5 | (1) | 7,833 | ||||||||||
Net income attributable to noncontrolling interests | 14,017 | 10,593 | 3,424 | |||||||||||||||
Net income attributable to LHC Group, Inc.’s common stockholders | $ | 73,923 | $ | 43,022 | $ | 30,901 |
(1) | Effective tax rate as a percentage of income from continuing operations attributable to our common stockholders, excluding the excess tax benefits realized and a change in our unrecognized tax position. For a discussion of our unrecognized tax position, which was assumed with the Merger on April 1, 2018, see Note 12 of the Notes to Condensed Consolidated Financial Statements, which is incorporated herein by reference. |
Nine Months Ended September 30, 2019 | |||||||||||||||||||||||||
Same Store(1) | De Novo(2) | Organic(3) | Organic Growth (Loss) % | Acquired (4) | Total | Total Growth (Loss) % | |||||||||||||||||||
Home health services | |||||||||||||||||||||||||
Revenue | $ | 679,286 | $ | — | $ | 679,286 | 7.2 | % | $ | 449,393 | $ | 1,128,679 | 20.3 | % | |||||||||||
Revenue Medicare | $ | 453,550 | $ | — | $ | 453,550 | 3.5 | $ | 335,723 | $ | 789,273 | 18.2 | |||||||||||||
Admissions | 169,501 | — | 169,501 | 8.6 | 117,018 | 286,519 | 19.5 | ||||||||||||||||||
Medicare Admissions | 98,383 | — | 98,383 | 2.5 | 73,960 | 172,343 | 15.5 | ||||||||||||||||||
Average Census | 46,910 | — | 46,910 | 5.1 | 29,663 | 76,573 | 0.6 | ||||||||||||||||||
Average Medicare Census | 29,644 | — | 29,644 | — | 19,774 | 49,418 | (2.7 | ) | |||||||||||||||||
Home Health Episodes | 163,612 | — | 163,612 | 0.1 | 113,139 | 276,751 | 13.3 | ||||||||||||||||||
Hospice services | |||||||||||||||||||||||||
Revenue | $ | 136,545 | $ | — | $ | 136,545 | 7.2 | $ | 30,952 | $ | 167,497 | 25.0 | |||||||||||||
Revenue Medicare | $ | 126,243 | $ | — | $ | 126,243 | 10.1 | $ | 27,501 | $ | 153,744 | 29.3 | |||||||||||||
Admissions | 11,227 | — | 11,227 | 5.9 | 2,519 | 13,746 | 16.7 | ||||||||||||||||||
Medicare Admissions | 9,969 | — | 9,969 | 6.8 | 2,246 | 12,215 | 6.9 | ||||||||||||||||||
Average Census | 3,379 | — | 3,379 | 8.9 | 623 | 4,002 | 13.6 | ||||||||||||||||||
Average Medicare Census | 3,127 | — | 3,127 | 9.0 | 570 | 3,697 | 13.7 | ||||||||||||||||||
Patient days | 926,927 | — | 926,927 | 9.5 | 166,112 | 1,093,039 | 13.5 | ||||||||||||||||||
Home and community-based services | |||||||||||||||||||||||||
Revenue | $ | 43,954 | $ | — | $ | 43,954 | 1.2 | $ | 117,632 | $ | 161,586 | 32.9 | |||||||||||||
Billable hours | 1,793,579 | — | 1,793,579 | 26.1 | 5,048,019 | 6,841,598 | 36.8 | ||||||||||||||||||
Facility-based services | |||||||||||||||||||||||||
LTACHs | |||||||||||||||||||||||||
Revenue | $ | 76,483 | $ | — | $ | 76,483 | (2.6 | ) | $ | 201 | $ | 76,684 | (6.3 | ) | |||||||||||
Patient days | 58,382 | — | 58,382 | (8.3 | ) | 142 | 58,524 | (11.1 | ) | ||||||||||||||||
Other facility-based services | |||||||||||||||||||||||||
Revenue | $ | 9,194 | $ | — | $ | 9,194 | 47.5 | $ | — | $ | 9,194 | 47.5 | |||||||||||||
HCI | |||||||||||||||||||||||||
Revenue | $ | — | $ | — | $ | — | — | $ | 24,444 | $ | 24,444 | 3.4 | |||||||||||||
Consolidated | |||||||||||||||||||||||||
Revenue | $ | 945,462 | $ | — | $ | 945,462 | 6.3 | $ | 622,622 | $ | 1,568,084 | 20.1 |
(1) | Same store — location that has been in service with us for greater than 12 months. |
(2) | De Novo — internally developed location that has been in service with us for 12 months or less. |
(3) | Organic — combination of same store and de novo. |
(4) | Acquired — purchased location that has been in service with us for 12 months or less, including all legacy Almost Family locations for the period after April 1, 2018. Almost Family locations remain counted as acquired locations due to continued system integrations, which will be completed by the end of 2019. |
Nine Months Ended September 30, | ||||||||||||
2019 | % of Net Service Revenue | 2018 | % of Net Service Revenue | |||||||||
Revenue | $ | 1,568,084 | $ | 1,319,840 | ||||||||
Less: Implicit price concession | 19,158 | 1.2 | % | 19,719 | 1.5 | % | ||||||
Net service revenue | $ | 1,548,926 | $ | 1,300,121 |
Nine Months Ended September 30, | |||||||||||||
2019 | 2018 | ||||||||||||
Home health services | |||||||||||||
Salaries, wages and benefits | $ | 635,966 | 57.1 | % | $ | 526,958 | 57.0 | % | |||||
Transportation | 32,755 | 2.9 | 29,483 | 3.2 | |||||||||
Supplies and services | 25,361 | 2.3 | 19,975 | 2.2 | |||||||||
Total | $ | 694,082 | 62.3 | % | $ | 576,416 | 62.4 | % | |||||
Hospice services | |||||||||||||
Salaries, wages and benefits | $ | 75,443 | 44.7 | % | $ | 69,321 | 47.4 | % | |||||
Transportation | 5,691 | 3.4 | 5,427 | 3.7 | |||||||||
Supplies and services | 22,719 | 13.5 | 20,809 | 14.2 | |||||||||
Total | $ | 103,853 | 61.6 | % | $ | 95,557 | 65.3 | % | |||||
Home and community-based services | |||||||||||||
Salaries, wages and benefits | $ | 116,674 | 74.0 | % | $ | 88,693 | 74.1 | % | |||||
Transportation | 1,636 | 1.0 | 1,215 | 1.0 | |||||||||
Supplies and services | 744 | 0.5 | 423 | 0.4 | |||||||||
Total | $ | 119,054 | 75.5 | % | $ | 90,331 | 75.5 | % | |||||
Facility-based services | |||||||||||||
Salaries, wages and benefits | $ | 37,696 | 44.7 | % | $ | 41,145 | 47.7 | % | |||||
Transportation | 219 | 0.3 | 238 | 0.3 | |||||||||
Supplies and services | 15,897 | 18.8 | 17,719 | 20.5 | |||||||||
Total | $ | 53,812 | 63.8 | % | $ | 59,102 | 68.5 | % | |||||
HCI | |||||||||||||
Salaries, wages and benefits | $ | 10,215 | 42.2 | % | $ | 10,017 | 42.5 | % | |||||
Transportation | 330 | 1.4 | 340 | 1.4 | |||||||||
Supplies and services | 274 | 1.1 | 55 | 0.2 | |||||||||
Total | $ | 10,819 | 44.7 | % | $ | 10,412 | 44.1 | % | |||||
Consolidated | |||||||||||||
Total | $ | 981,620 | 63.4 | % | $ | 831,818 | 64.0 | % |
Nine months ended September 30, | |||||||||||||
2019 | 2018 | ||||||||||||
Home health services | |||||||||||||
General and administrative | $ | 314,746 | 28.3 | % | $ | 270,126 | 29.2 | % | |||||
Depreciation and amortization | 7,369 | 0.7 | 6,949 | 0.8 | |||||||||
Total | $ | 322,115 | 29.0 | % | $ | 277,075 | 30.0 | % | |||||
Hospice services | |||||||||||||
General and administrative | $ | 43,856 | 26.0 | % | $ | 41,325 | 28.3 | % | |||||
Depreciation and amortization | 1,311 | 0.8 | 1,765 | 1.2 | |||||||||
Total | $ | 45,167 | 26.8 | % | $ | 43,090 | 29.5 | % | |||||
Home and community-based services | |||||||||||||
General and administrative | $ | 32,038 | 20.3 | % | $ | 28,206 | 23.6 | % | |||||
Depreciation and amortization | 966 | 0.6 | 458 | 0.4 | |||||||||
Total | $ | 33,004 | 20.9 | % | $ | 28,664 | 24.0 | % | |||||
Facility-based services | |||||||||||||
General and administrative | $ | 25,700 | 30.5 | % | $ | 27,541 | 31.9 | % | |||||
Depreciation and amortization | 2,310 | 2.7 | 2,030 | 2.4 | |||||||||
Total | $ | 28,010 | 33.2 | % | $ | 29,571 | 34.3 | % | |||||
HCI | |||||||||||||
General and administrative | $ | 11,482 | 47.4 | % | $ | 11,633 | 49.4 | % | |||||
Depreciation and amortization | 856 | 3.5 | 784 | 3.3 | |||||||||
Total | $ | 12,338 | 50.9 | % | $ | 12,417 | 52.7 | % | |||||
Consolidated | |||||||||||||
Total | $ | 440,634 | 28.4 | % | $ | 390,817 | 30.1 | % |
Nine months ended September 30, | |||||||
2019 | 2018 | ||||||
Net cash provided by (used in): | |||||||
Operating activities | $ | 104,790 | $ | 86,334 | |||
Investing activities | (69,521 | ) | (9,819 | ) | |||
Financing activities | (55,330 | ) | (22,391 | ) | |||
Change in cash | $ | (20,061 | ) | $ | 54,124 | ||
Cash at beginning of period | 49,363 | 2,849 | |||||
Cash at end of period | $ | 29,302 | $ | 56,973 |
Leverage Ratio | Eurodollar Margin | Base Rate Margin | Commitment Fee Rate | ||||||
≤1.00:1.00 | 1.50 | % | 0.50 | % | 0.200 | % | |||
>1.00:1.00 ≤ 2.00:1.00 | 1.75 | % | 0.75 | % | 0.250 | % | |||
>2.00:1.00 ≤ 3.00:1.00 | 2.00 | % | 1.00 | % | 0.300 | % | |||
>3.00:1.00 | 2.25 | % | 1.25 | % | 0.350 | % |
3.1 | |
3.2 | |
4.1 | |
10.1 | |
31.1 | |
31.2 | |
32.1* | |
101.INS | XBRL Instance - The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
101.SCH | |
101.CAL | |
101.DEF | |
101.LAB | |
101.PRE |
LHC GROUP, INC. | ||
(Registrant) | ||
Date: November 7, 2019 | /s/ Joshua L. Proffitt | |
Joshua L. Proffitt | ||
Chief Financial Officer (Principal financial officer) |
Page | ||||
1. | Employment | 1 | ||
2. | Term | 1 | ||
3. | Extent of Service | 2 | ||
4. | Compensation and Benefits | |||
(a) | Base Salary | 2 | ||
(b) | Incentive, Savings and Retirement Plans | 2 | ||
(c) | Welfare Benefit Plans | 2 | ||
(d) | Expenses | 3 | ||
(e) | Fringe Benefits | 3 | ||
(f) | Vacation | 3 | ||
(g) | Office and Support Staff | 3 | ||
(h) | Annual Compensation Review | 3 | ||
(i) | One-Time Equity Grant | 3 | ||
5. | Change of Control | 3 | ||
6. | Termination of Employment | 5 | ||
(a) | Death or Retirement | 5 | ||
(b) | Disability | 5 | ||
(c) | Termination by the Company | 5 | ||
(d) | Termination by Executive | 6 | ||
(e) | Notice of Termination | 6 | ||
(f) | Date of Termination | 7 | ||
7. | Obligations of the Company upon Termination | 7 | ||
(a) | Termination by Executive for Good Reason; Termination by the Company Other Than for Cause or Disability | 7 | ||
(b) | Death or Disability | 9 | ||
(c) | Cause, Voluntary Termination without Good Reason or Retirement | 10 | ||
(d) | Expiration of Term Following Notice | 10 | ||
(e) | Resignations | 10 | ||
8. | Non-exclusivity of Rights | 10 | ||
9. | Full Settlement; No Obligation to Mitigate | 10 | ||
10. | Certain Additional Payments by the Company | 11 | ||
11. | Costs of Enforcement | 12 | ||
12. | Restrictions on Conduct of Executive | 12 | ||
(a) | General | 12 | ||
(b) | Definitions | 13 | ||
(c) | Restrictive Covenants | 15 | ||
(d) | Enforcement of Restrictive Covenants | 17 | ||
13. | Consent to Jurisdiction | 18 | ||
14. | Assignment and Successors | 18 | ||
15. | Miscellaneous | 18 | ||
(a) | Waiver | 18 |
(b) | Severability | 18 | ||
(c) | Other Agents | 19 | ||
(d) | Entire Agreement | 19 | ||
(e) | Governing Law | 19 | ||
(f) | Notices | 19 | ||
(g) | Amendments and Modifications | 19 | ||
(h) | Construction | 19 | ||
(i) | Code Section 409A | 20 | ||
(j) | Withholding | 20 |
1. | I have reviewed this Quarterly Report on Form 10-Q of LHC Group, Inc. for the quarter ended September 30, 2019; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ Keith G. Myers | |
Keith G. Myers | |
Chief Executive Officer (Principal executive officer) |
1. | I have reviewed this Quarterly Report on Form 10-Q of LHC Group, Inc. for the quarter ended September 30, 2019; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
(b) | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
(c) | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
(d) | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s Board of Directors (or persons performing the equivalent functions): |
(a) | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
/s/ Joshua L. Proffitt | |
Joshua L. Proffitt | |
Chief Financial Officer | |
(Principal financial officer) |
1. | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ Keith G. Myers | |
Keith G. Myers | |
Chief Executive Officer | |
(Principal executive officer) | |
/s/ Joshua L. Proffitt | |
Joshua L. Proffitt | |
Chief Financial Officer | |
(Principal financial officer) |
Segment Information |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Information | Segment Information The Company's reporting segments include (1) home health services, (2) hospice services, (3) home and community-based services, (4) facility-based services and (5) healthcare innovations (“HCI”). The accounting policies of the segments are the same as those described in the summary of significant accounting policies, as described in Note 2 of the Notes to Condensed Consolidated Financial Statements. Reportable segments have been identified based upon how management has organized the business by services provided to customers and how the chief operating decision maker manages the business and allocates resources, consistent with the criteria in ASC 280, Segment Reporting. The following tables summarize the Company’s segment information for the three and nine months ended September 30, 2019 and 2018 (amounts in thousands):
|
Commitments and Contingencies |
9 Months Ended |
---|---|
Sep. 30, 2019 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies Contingencies Regulatory Matters The Company provides services in a highly regulated industry and is a party to various proceedings and regulatory and other governmental and internal audits and investigations in the ordinary course of business (including audits by Zone Program Integrity Contractors ("ZPICs") and Recovery Audit Contractors ("RACs") and investigations resulting from the Company's obligation to self-report suspected violations of law). Management cannot predict the ultimate outcome of any regulatory and other governmental and internal audits and investigations. While such audits and investigations are the subject of administrative appeals, the appeals process, even if successful, may take several years to resolve. The Department of Justice, CMS, or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company's businesses. These audits and investigations have caused and could potentially continue to cause delays in collections, recoupments from governmental payors. Currently, the Company has recorded $16.9 million in other assets, which are due from government payors related to the disputed finding of pending appeals of ZPIC audits. Additionally, these audits may subject the Company to sanctions, damages, extrapolation of damage findings, additional recoupments, fines, and other penalties (some of which may not be covered by insurance), which may, either individually or in the aggregate, have a material adverse effect on the Company's business and financial condition. Merger Related Litigation On January 18, 2018, Jordan Rosenblatt, a purported shareholder of Almost Family filed a complaint for violations of the Securities Exchange Act of 1934 in the United States District Court for the Western District of Kentucky, styled Rosenblatt v. Almost Family, Inc., et al., Case No. 3:18-cv-40-TBR (the “Rosenblatt Action”). The Rosenblatt Action was filed against the Company, Almost Family, Almost Family’s board of directors, and Merger Sub. The complaint in the Rosenblatt Action (“Rosenblatt Complaint”) asserts, among other things, that the Form S-4 Registration Statement (“Registration Statement”) filed on December 21, 2017 in connection with the Merger contained false and misleading statements with respect to the Merger. The Rosenblatt Action sought, among other things, an injunction enjoining the Merger from closing and an award of attorneys’ fees and costs. In addition to the Rosenblatt Action, two additional complaints were filed against Almost Family in the United States District Court for the District of Delaware (the "Delaware Actions") alleging similar violations as the Rosenblatt Action. These Delaware Actions also sought, among other things, to enjoin both the vote of the Almost Family stockholders with respect to the Merger and the closing of the Merger, monetary damages, and an award of attorneys’ fees and costs from Almost Family. On February 22, 2018, plaintiffs in the Delaware Actions moved for a preliminary injunction to enjoin the merger of Almost Family and Merger Sub. Then, on March 2, 2018, the Delaware Actions were transferred to the United States District Court for the Western District of Kentucky. Shortly thereafter, on March 12, 2018, Almost Family, the Company, and Merger Sub opposed the plaintiffs’ motion for a preliminary injunction, and the court heard oral argument on the plaintiffs’ motion for a preliminary injunction on March 19, 2018. On March 22, 2018, the court denied plaintiffs’ motion for preliminary injunction. The next day, on March 23, 2018, one of the plaintiffs in the Delaware Actions moved to consolidate the Delaware Actions with the Rosenblatt Action and for the appointment of a lead plaintiff. On December 19, 2018, the Court granted the motion to consolidate, appointed Leonard Stein, a purported Almost Family shareholder, as the Lead Plaintiff, and approved Stein's selection of Lead Counsel. On February 1, 2019, Lead Plaintiff filed his Consolidated Amended Class Action Complaint (the "Consolidated Complaint"). The Consolidated Complaint asserts claims against Almost Family, the Company and Almost Family's board of directors for violations of Section 14(a) of the 1934 Act in connection with the dissemination of the Company's and Almost Family's Proxy Statement concerning the Merger, and asserts breach of fiduciary duty claims and claims for violations of Section 20(a) of the 1934 Act against Almost Family's former board of directors. The Consolidated Complaint seeks, among other things, monetary damages and an award of attorneys' fees and costs. On April 12, 2019, the Company moved to dismiss the Consolidated Complaint and filed a motion to strike an affidavit attached to the Consolidated Complaint. Lead Plaintiff opposed the Company's motions on May 28, 2019, and the Company submitted reply briefs in support of its motions on June 19, 2019. The Company's motions are currently pending before the court. We believe that the claims asserted in these lawsuits are entirely without merit and intend to defend these lawsuits vigorously. Other Litigation We are involved in various other legal proceedings arising in the ordinary course of business. Although the results of litigation cannot be predicted with certainty, we believe the outcome of pending litigation will not have a material adverse effect, after considering the effect of our insurance coverage, on our consolidated financial information. Joint Venture Buy/Sell Provisions Most of the Company’s joint ventures include a buy/sell option that grants to the Company and its joint venture partners the right to require the other joint venture party to either purchase all of the exercising member’s membership interests or sell to the exercising member all of the non-exercising member’s membership interest, at the non-exercising member’s option, within 30 days of the receipt of notice of the exercise of the buy/sell option. In some instances, the purchase price is based on a multiple of the historical or future earnings before income taxes and depreciation and amortization of the equity joint venture at the time the buy/sell option is exercised. In other instances, the buy/sell purchase price will be negotiated by the partners and subject to a fair market valuation process. Compliance The laws and regulations governing the Company’s operations, along with the terms of participation in various government programs, regulate how the Company does business, the services offered and its interactions with patients and the public. These laws and regulations, and their interpretations, are subject to frequent change. Changes in existing laws or regulations, or their interpretations, or the enactment of new laws or regulations could materially and adversely affect the Company’s operations and financial condition. The Company is subject to various routine and non-routine governmental reviews, audits and investigations. In recent years, federal and state civil and criminal enforcement agencies have heightened and coordinated their oversight efforts related to the health care industry, including referral practices, cost reporting, billing practices, joint ventures and other financial relationships among health care providers. Violation of the laws governing the Company’s operations, or changes in the interpretation of those laws, could result in the imposition of fines, civil or criminal penalties and/or termination of the Company’s rights to participate in federal and state-sponsored programs and suspension or revocation of the Company’s licenses. The Company believes that it is in material compliance with all applicable laws and regulations.
|
Acquisitions and Joint Venture Activities |
9 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combinations [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Acquisitions and Joint Venture Activities | Acquisitions and Joint Venture Activities The Merger On April 1, 2018, the Company completed the Merger with Almost Family. At the effective time of the Merger on April 1, 2018, each outstanding share of common stock of Almost Family, other than certain canceled shares, was converted into the right to receive 0.9150 shares of the Company’s common stock and cash in lieu of any fractional shares of any Company common stock that Almost Family shareholders would otherwise have been entitled to receive. As a result, the Company issued approximately 12.8 million shares of its common stock to former stockholders of Almost Family, while also converting outstanding employee share awards, which resulted in total merger consideration of approximately $795.4 million. The Company was determined to be the accounting acquirer in the Merger. The Company's final valuation analysis of identifiable assets and liabilities assumed for the Merger in accordance with the requirements of ASC Topic 805, Business Combinations, are presented in the table below (amounts in thousands):
Acquisitions The Company acquired the majority-ownership of 14 home health agencies, six hospice agencies, two home and community-based agencies, and one LTACH location during the nine months ended September 30, 2019. The total aggregate purchase price for these transactions was $57.9 million, of which $54.1 million was paid in cash. The purchase prices were determined based on the Company’s analysis of comparable acquisitions and the target market’s potential future cash flows. Goodwill generated from the acquisitions was recognized based on the expected contributions of each acquisition to the overall corporate strategy. The Company expects its portion of goodwill to be fully tax deductible. The acquisitions were accounted for under the acquisition method of accounting. Accordingly, the accompanying interim financial information includes the results of operations of the acquired entities from the date of acquisition. The following table summarizes the aggregate consideration paid for the acquisitions and the amounts of the assets acquired and liabilities assumed at the acquisition dates, as well as their fair value at the acquisition dates and the noncontrolling interest acquired during the nine months ended September 30, 2019:
Trade names, certificates of need and licenses are indefinite-lived assets and, therefore, not subject to amortization. Acquired trade names that are not being used actively are amortized over the estimated useful life on the straight line basis. Trade names are valued using the relief from royalty method, a form of the income approach. Certificates of need are valued using the replacement cost approach based on registration fees and opportunity costs. Licenses are valued based on the estimated direct costs associated with recreating the asset, including opportunity costs based on an income approach. In the case of states with a moratorium in place, the licenses are valued using the multi-period excess earnings method. The other identifiable assets include customer relationships that are amortized over 20.0 years. Customer relationships were valued using the multi-period excess earnings method. Noncontrolling interest is valued at fair value. Joint Venture Activities During the nine months ended September 30, 2019, the Company acquired the minority ownership interests associated with certain agencies previously operated within three of its equity joint ventures, whereby such agencies became wholly-owned subsidiaries of the Company. The total consideration for the purchase of such ownership interests was $18.8 million, which was paid in cash. These transactions were accounted for as equity transactions. |
Significant Accounting Policies - Shares Used in Computation of Basic and Diluted Per Share Information (Details) - shares |
3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2019 |
Sep. 30, 2018 |
Sep. 30, 2019 |
Sep. 30, 2018 |
|
Accounting Policies [Abstract] | ||||
Weighted average number of shares outstanding for basic per share calculation (in shares) | 30,971 | 30,750 | 30,919 | 26,393 |
Effect of dilutive potential shares: | ||||
Nonvested stock (in shares) | 276 | 334 | 284 | 248 |
Adjusted weighted average shares for diluted per share calculation (in shares) | 31,247 | 31,084 | 31,203 | 26,641 |
Anti-dilutive shares (in shares) | 4 | 16 | 141 | 58 |
3;E2 KQ%I^
MA'ODU",/# [W;'=N4MM*NE&(8;+=JD&DI$H#[FNJ"8GS
M%AJFU;3 U&U1"-.O,$63[6"<5SL);_RV;3([76ZJGH$!HB:G^8PJ$%TB 26M
M.81V79>9Y%A=2# LC>MMB 6IWU3!?!]@"E]-D"[&U!)\H, +'=YJD-E]&N@"QO1F]BJZK6Y^E9+RJ'P41?_ J%GT[F'T\4YM?FZ:6K3L
M?U=M#__VE\?[KZ_Q3_=VK-LL#D="8?(Y\=[#D9*>KRGZ#&I,[ S"7XL=K,U
M%S"FX__W^/"/\Y-_'M\N]WKMEW!M!NKK:\L=^BJ(AE46$^V,V]N%EK7=LYH4
MV/+NK JUW7/S;%'&,'V<\GO[>9H0JW]_\N;D/#I8_<%>I1&_17@H:CN42E'*
MM3",S]^?G$6GQQ^.#\Z.HZT'>N@/J+>@07CAU$%RUUE[][_A?R:X]]_F?[UH
M?Q?_[<_L=_!,J[L]H":# W')*"^-+RMFY&I*,
M@K)8N86P$,?. ^@,].;0&T-E0([D&C7//+BN=SS8[K5\9^QA)V>!&;=!!*[D
ML!"V1:%O@0USD<*8
M2C2Q53F"NUJ2S\;E[JH#D#G) X3'8J!#:UTZ#TF?-!R2/EZ@05U*\I3X4^A+
MW))"@@E:Z.@A!=E1+?*C%Z(8R@H&!B\TQ_6&.23?/76;0S?_T"WYU,$H%3)S
M5*B P9-79+[RBRZ-'0P&.(%")P]U:"U @,I B8XOX*1QJ$W[: K=T1-U/OH=
M8 !&IHAI+16\298MU'"QZ"
M3],3Q]_,H*W!H,> QP+>K578#>G_ *4M7H;2]E6F [3YM*_DCBI:E\$M,SNO8SL)X;J2->>EJ[ 5J,*ILPJXD0/)?:;O1?
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M>A[C,Q64O#K^6^A,LQ#PK'+/EUXT3?2&]27G$!/;^3H:YZV!WC,*O:A^77
M/H$HX,3 &N+$4+N7P3T5W#)M%M'Q#AV7X7B;2 0V[8V2I J))?CRVG>3S,(B
M^:*RM?Z=4T0/609K% >)UZX!='?'1)J-EYIWOW7#E9$*2^D"
UA/!H^I4_IS(BJL(\0_42JHU !@N,8"0N>YX%\<
MR,2_;!B2+BC$E,8CN-JL+/T(*[^V$7'MV>"F_@B&.!="(F%2&)-<]PV/[)AL ZJ:8/&\HLJFFG2_/6(KI/)<+LF:BHU(Z-CV;VFSRGS7.7_=(^^OYE'!2[_W,K2YB=],9K0)W"0>GP!R
M82)T\Q@P?%+) HIS^0-N:?/YL5F+.:'T#!,,UR-S#>$MM_3Z"Q*#M@FQ=#_U
M=^%(="'#G%A^HQXUAI4\#+JY!=+Z=2@HJ9>.U_&+\.;/@^Q-&_>@AW0LD8Y/
M7S'FGAGTO/WLW,Z.76O,PXX>A"&V"3)-;KC)@9^4VP45Z-9-V1*+.7,,B-Q&
MXL:3RDMHY7L#LN,BKM:"Z7F]R3'" 41QI$$X>!DTGZ?)"0TZ[.%/ZVB.2T?A
MQ]@,2:V8Y7ZC+(;Q0>^KZ8FEAY;IEMJ=*9/A8OO^&\U"MKZ#Q
,^IHO(4,;K3+\D[UK>1F?=%)+B
MG%<_WO!9HR75>4"LYZD4YA?4=M4*CV0]A!,5HCB1F8&:F@D
M+3ZCQA,.&[1X3=VTCSO\W7=BX*)3*+KT-[EC7![A(0@W4EE/>W&ZKZ)N+Y:"
MX*DX!LQ2(F@O;,3C3Y6N=IE,W.K2' /32=CPR6ZT*7\9
MBT0:=J#L?K4@ UA=+/W&R\:#-_.<<5'NL$6;#:FN/#T4_IB.0!J[QY*4-.+J(]<%RU PNLMLL0!>=(&M4&DG
M&ZZ *]=<@UMR_4M!/EUV._B^67C"I4BY!_IJ)2LK 457A
MI#Z)LA0UZ*<7QFOT^4+*>)3W\>K/U-L _EO&,D>F_T6D8S T8(?P[S(FFS.3
MK/AKQ;6N,C%F;1,5<8/>P-]\J&,EC6UZ2B\\$P6(#=(TY!C,7?2:G=5CLFG.
MZJG(<"3G8I;F\(556&$G2T5.KHN:Y-%7P6OO),2&%]R%%[P[_GSZ[B=KJ0?5
MA6)+SC*#[*(D]S:REC[84N+6:H5;#G>T2>;RR6<;:P
MJ+2S>B2J$1(N_05?#NE+68 E*$,G.'NT80%B\G6CAQTX"Y9$D!,\1]LZGTHD
M:;"3RPG:Q@GYNJ?CMD!8H)*%KY;1V9!32=R
M%J&L'/=4FJSJ9:+OK*)$+4<9J5RM!TTXJDLHS'J-+R;4SS&?-67M&0=IJA"1
MFD?GN9;QF[OSGV>=A40@ES.QYE^'24(7VJ&\[>FG'=,%2_KX>I\3MF